Veloxis Announces the Total Number of Shares and Voting

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Veloxis Announces the Total Number of Shares and Voting Rights

Company Announcement no. 22/2016  

To: NASDAQ OMX Copenhagen A/S                        Copenhagen, Denmark, 30 September 2016

Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 30 September 2016

Veloxis Pharmaceuticals A/S announces in accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations , the total number of shares and voting rights in the company at the end of a calendar month in which changes to the share capital have occurred.   

With reference to Company Announcements no. 20/2016 dated 6 September 2016 and no. 21/2016 dated 20 September 2016 informing of an increase in the share capital and the voting rights after exercise of employee warrants, the table below provides the total number of shares and voting rights in Veloxis as of 30 September 2016.

Date Total number of shares (nominal value of DKK 0.10 each) Share capital (nominal value in DKK) Total number of votes
30 September 2016 1,701,873,881 170,187,388.10 1,701,873,881

     

For more information, please contact:

Craig A. Collard           

President & CEO                      

Phone: +1 919 524 4317                    

Email: cac@veloxis.com                       

     

About Veloxis Pharmaceuticals

Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a commercial-stage specialty pharmaceutical company committed to improving the lives of transplant patients.  A Danish company, Veloxis Pharmaceuticals A/S operates in the U.S. through Veloxis Pharmaceuticals Inc., a wholly-owned subsidiary headquartered in Cary, North Carolina, USA and maintains a second corporate office in Edison, New Jersey, USA.  Veloxis has successfully developed Envarsus XR (tacrolimus extended-release tablets) based upon the company's unique and patented delivery technology, MeltDose®, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets around the world, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.  For further information, please visit www.veloxis.com .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Box to Box Films Partners with Berk Communications for Growth

Updated Category News Views 143

Box to Box Films Teams with Berk Communications for Strategic Growth The production studio selects sports and entertainment leader to elevate its voice across culture, sport, and entertainment. Supporting a New Era for Box to Box Films As the company enters a critical phase of growth, its portfolio continues to broaden, embracing a variety of formats and collaborators....

Continue Reading
Cryptocurrency Markets Soar: What's Next for Bitcoin and Friends?

Updated Category News Views 136

Cryptocurrency Markets on the Rise The cryptocurrency markets experienced a notable recovery recently, with various altcoins rallying alongside Bitcoin. Ethereum emerged as a leading force in this resurgence, significantly impacting the market dynamics. Current Pricing Overview Here's a snapshot of some prominent cryptocurrencies: Bitcoin (BTC): Trading at $119,157.24...

Continue Reading
What Investors Are Anticipating in AbbVie Options Market

Updated Category News Views 149

Understanding AbbVie's Bullish Sentiment Among Investors Investors are demonstrating considerable confidence in AbbVie (NYSE: ABBV) as they engage in bullish trading behaviors. This indicates a strong belief that the stock will perform positively in the near future, suggesting that investors may be anticipating significant developments or outcomes related to the company....

Continue Reading
Echandia Expands Global Market with Canadian Coast Guard Contract

Updated Category News Views 158

Exciting New Chapter for Echandia in Sustainable Maritime Solutions Echandia, a pioneering force in advanced maritime battery systems, is making headlines with a significant contract to provide a 3.7 MWh battery system for a new hybrid icebreaker being constructed for the Canadian Coast Guard. This contract signifies a momentous step into the Canadian market, amplifying...

Continue Reading
Moolec Science SA's Short Interest: Key Insights for Traders

Updated Category News Views 142

Short Interest Snapshot: What’s the Shift? Looking at Moolec Science SA (NYSE: MLEC), short interest is a hot topic—like watching the stock market over a diner breakfast. It’s been a rollercoaster, folks. That short interest as a percent of float has taken a dive—down a hefty 36.93% since the last report. Let me spell it out: 23 thousand shares are sold short,...

Continue Reading